{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T13:20:14Z","timestamp":1719235214411},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T00:00:00Z","timestamp":1538524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Emerg Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12245-018-0202-y","type":"journal-article","created":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:42:49Z","timestamp":1538563369000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Idarucizumab for a traumatic head injury patient taking dabigatran"],"prefix":"10.1186","volume":"11","author":[{"given":"Shuhei","family":"Maruyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuji","family":"Kanayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromu","family":"Iwamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiki","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fukuki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Nakamori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kuwagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,3]]},"reference":[{"key":"202_CR1","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.2146\/ajhp160756","volume":"74","author":"AA Alalwan","year":"2017","unstructured":"Alalwan AA, Voils SA, Hartzema AG. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation. Am J Health Syst Pharm. 2017;74:1237\u201344.","journal-title":"Am J Health Syst Pharm"},{"key":"202_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.amjcard.2017.05.055","volume":"120","author":"JM Ashburner","year":"2017","unstructured":"Ashburner JM, Singer DE, Lubitz SA, Borowsky LH, Atlas SJ. Changes in use of anticoagulation in patients with atrial fibrillation within a primary care network associated with the introduction of direct oral anticoagulants. Am J Cardiol. 2017;120:786\u201391.","journal-title":"Am J Cardiol"},{"key":"202_CR3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet"},{"key":"202_CR4","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1136\/heartjnl-2015-307489","volume":"101","author":"D Caldeira","year":"2015","unstructured":"Caldeira D, Rodrigues FB, Barra M, Santos AT, de Abreu D, Gon\u00e7alves N, et al. Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Heart. 2015;101:1204\u201311.","journal-title":"Heart"},{"key":"202_CR5","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.thromres.2016.01.004","volume":"139","author":"JD Douketis","year":"2016","unstructured":"Douketis JD, Healey JS, Brueckmann M, Fraessdorf M, Spyropoulos AC, Wallentin L, et al. Urgent surgery or procedures in patients taking dabigatran or warfarin: analysis of perioperative outcomes from the RE-LY trial. Thromb Res. 2016;139:77\u201381.","journal-title":"Thromb Res"},{"key":"202_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1097\/TA.0000000000001245","volume":"81","author":"JM Feeney","year":"2016","unstructured":"Feeney JM, Santone E, DiFiori M, Kis L, Jayaraman V, Montgomery SC. Compared to warfarin, direct oral anticoagulants are associated with lower mortality in patients with blunt traumatic intracranial hemorrhage: a TQIP study. J Trauma Acute Care Surg. 2016;81:843\u20138.","journal-title":"J Trauma Acute Care Surg"},{"key":"202_CR7","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1089\/neu.2012.2348","volume":"29","author":"J Zhang","year":"2012","unstructured":"Zhang J, Jiang R, Liu L, Watkins T, Zhang F, Dong JF. Traumatic brain injury-associated coagulopathy. J Neurotrauma. 2012;29:2597\u2013605.","journal-title":"J Neurotrauma"},{"key":"202_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/jth.13227","volume":"14","author":"JH Levy","year":"2016","unstructured":"Levy JH, Ageno W, Chan NC, Crowther M, Verhamme P, Weitz JI, et al. When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14:623\u20137.","journal-title":"J Thromb Haemost"},{"key":"202_CR9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1097\/TA.0b013e3182a07391","volume":"75","author":"JL Gordon","year":"2013","unstructured":"Gordon JL, Fabian TC, Lee MD, Dugdale M. Anticoagulant and antiplatelet medications encountered in emergency surgery patients: a review of reversal strategies. J Trauma Acute Care Surg. 2013;75:475\u201386.","journal-title":"J Trauma Acute Care Surg"},{"key":"202_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1385\/NCC:1:4:479","volume":"1","author":"SC Stein","year":"2004","unstructured":"Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. 2004;1:479\u201388.","journal-title":"Neurocrit Care"},{"key":"202_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1001\/archsurg.1996.01430210021004","volume":"131","author":"F Hulka","year":"1996","unstructured":"Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg. 1996;131:923\u20137.","journal-title":"Arch Surg"},{"key":"202_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00701-007-1475-8","volume":"150","author":"BS Harhangi","year":"2008","unstructured":"Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir. 2008;150:165\u201375.","journal-title":"Acta Neurochir"},{"key":"202_CR13","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/02688697.2011.552650","volume":"25","author":"Y Sun","year":"2011","unstructured":"Sun Y, Wang J, Wu X, Xi C, Gai Y, Liu H, et al. Validating the incidence of coagulopathy and disseminated intravascular coagulation in patients with traumatic brain injury--analysis of 242 cases. Br J Neurosurg. 2011;25:363\u20138.","journal-title":"Br J Neurosurg"},{"key":"202_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/TA.0b013e318190c3c0","volume":"66","author":"P Talving","year":"2009","unstructured":"Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D. Coagulopathy in severe traumatic brain injury: a prospective study. J Trauma. 2009;66:55\u201361.","journal-title":"J Trauma"},{"key":"202_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/neu.2011.2044","volume":"29","author":"G Franschman","year":"2012","unstructured":"Franschman G, Boer C, Andriessen TM, van der Naalt J, Horn J, Haitsma I, et al. Multicenter evaluation of the course of coagulopathy in patients with isolated traumatic brain injury: relation to CT characteristics and outcome. J Neurotrauma. 2012;29:128\u201336.","journal-title":"J Neurotrauma"},{"key":"202_CR16","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1097\/TA.0b013e3182218cd8","volume":"71","author":"AP Cap","year":"2011","unstructured":"Cap AP, Spinella PC. Severity of head injury is associated with increased risk of coagulopathy in combat casualties. J Trauma. 2011;71:S78\u201381.","journal-title":"J Trauma"},{"key":"202_CR17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1111\/j.1365-2702.2010.03618.x","volume":"20","author":"YJ Kim","year":"2011","unstructured":"Kim YJ. A systematic review of factors contributing to outcomes in patients with traumatic brain injury. J Clin Nurs. 2011;20:1518\u201332.","journal-title":"J Clin Nurs"}],"container-title":["International Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-018-0202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12245-018-0202-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12245-018-0202-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T23:10:44Z","timestamp":1570057844000},"score":1,"resource":{"primary":{"URL":"https:\/\/intjem.biomedcentral.com\/articles\/10.1186\/s12245-018-0202-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,3]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["202"],"URL":"https:\/\/doi.org\/10.1186\/s12245-018-0202-y","relation":{},"ISSN":["1865-1372","1865-1380"],"issn-type":[{"value":"1865-1372","type":"print"},{"value":"1865-1380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,3]]},"assertion":[{"value":"10 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"We have written consent from the involved patient to present this case; the consent form will be provided upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"41"}}